Sandro Porceddu

Add links
From Wikipedia, the free encyclopedia

Sandro Porceddu is a head and neck radiation oncologist at Brisbane's Princess Alexandra Hospital and a Professor with the University of Queensland.[1] He was president of the Clinical Oncologic Society of Australia (COSA)[2] and chair of the Trials Scientific Committee of the Trans Tasman Radiation Oncology Group (TROG).[3]

Academic career[edit]

Porceddu was awarded a doctorate of medicine for his research into improving the integration of radiotherapy in the management of head and neck cancer and received the American Head and Neck Society/ANZ Head and Neck Cancer Society Christopher O'Brien Traveling Scholarship. He is chair of a phase 3 clinical trial group to assess radiation therapy alone versus in combination with carboplatin chemotherapy for the post-operative treatment of head and neck cancers.[4]

Publications[edit]

  1. Sandro V Porceddu (2013). "Does fluorodeoxyglucose PET add to the management of the neck following curative radiotherapy in head and neck cancer compared with computed tomography?". Expert Rev Anticancer Ther. 13 (3): 279–84. doi:10.1586/era.13.10. PMID 23477515. S2CID 207214576.
  2. Sandro V Porceddu (2005). "Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer". Head Neck. 27 (3): 175–81. CiteSeerX 10.1.1.469.8139. doi:10.1002/hed.20130. PMID 15627258. S2CID 21375769.
  3. Sandro V Porceddu (2007). "Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial"". Radiother Oncol. 85 (3): 456–62. doi:10.1016/j.radonc.2007.10.020. PMID 18036689.
  4. Sandro V Porceddu (2008). "Role of functional imaging in head and neck squamous cell carcinoma: fluorodeoxyglucose positron emission tomography and beyond". Hematol Oncol Clin North Am. 22 (6): 1221–38, ix–x. doi:10.1016/j.hoc.2008.08.009. PMID 19010270.
  5. S V Porceddu (2008). "Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: a clinician's guide". J Med Imaging Radiat Oncol. 52 (5): 491–6. doi:10.1111/j.1440-1673.2008.02001.x. PMID 19032396. S2CID 38368939.
  6. Sandro V Porceddu (2011). "Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy". Head Neck. 33 (12): 1675–82. doi:10.1002/hed.21655. PMID 22076976. S2CID 3727485.
  7. J Corry (2008). "Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation". J Med Imaging Radiat Oncol. 52 (5): 503–510. doi:10.1111/j.1440-1673.2008.02003.x. PMID 19032398. S2CID 34975490.
  8. D I Pryor (2011). "Distinct patterns of stomatitis with concurrent cetuximab and radiotherapy for head and neck squamous cell carcinoma". Oral Oncol. 1747 (10): 984–7. doi:10.1016/j.oraloncology.2011.07.023. PMID 21852185.
  9. M K Ng (2005). "Parotid-sparing radiotherapy: does it really reduce xerostomia?". Clin Oncol (R Coll Radiol). 17 (8): 610–7. doi:10.1016/j.clon.2005.06.012. PMID 16372486.
  10. Sandro V. Porceddu; Belinda Campbell; Danny Rischin; June Corry; LeAnn Weih; Mario Guerrieri; Marissa Grossi; Lester J. Peters (1 October 2004). "Postoperative chemoradiotherapy for high-risk head-and-neck squamous cell carcinoma". International Journal of Radiation Oncology, Biology, Physics. 60 (2): 365–373. doi:10.1016/j.ijrobp.2004.03.011. PMID 15380568.
  11. David I Pryor; Benjamin Solomon; Sandro V Porceddu (September 2011). "The emerging era of personalized therapy in squamous cell carcinoma of the head and neck". Asia-Pacific Journal of Clinical Oncology. 7 (3): 236–251. doi:10.1111/j.1743-7563.2011.01420.x. PMID 21884435. S2CID 24908321.

References[edit]

[5] [6] [7] [8]

  1. ^ Bridie Jabour Scans spare PA patients from knife Brisbane Times August 3, 2011
  2. ^ Australia, Cancer Council. "Board and governance - Cancer Council Australia". www.cancer.org.au. Retrieved 26 February 2020.
  3. ^ "TROG Cancer Research". www.trog.com.au. Retrieved 26 February 2020.
  4. ^ Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck ClinicalTrials.gov
  5. ^ "Sandro Porceddu » COSA-IPOS 2012". Archived from the original on 5 September 2013. Retrieved 6 August 2015.
  6. ^ Cathy O'Leary Warning over virus link to cancers The West Australian March 19, 2013
  7. ^ "Archived copy" (PDF). Archived from the original (PDF) on 21 April 2013. Retrieved 6 August 2015.{{cite web}}: CS1 maint: archived copy as title (link)
  8. ^ Associate Professor Sandro Porceddu UQ Researchers


Stub icon 1 Stub icon 2

This biographical article related to medicine in Australia is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Sandro_Porceddu&oldid=1177522619"